Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development (including $718 and $0 of stock compensation to officers, directors and employees during the years ended December 31, 2022 and 2021, respectively) 8,811 9,591
Selling, general and administrative (including $3,903 and $17,234 of stock compensation to officers, directors and employees during the years ended December 31, 2022 and 2021, respectively) 12,446 47,924
Total Operating Expenses 21,257 57,515
Loss from Operations (21,257) (57,515)
Other (Income) Expense    
Interest income (292) (38)
Interest expense 8 718
Change in fair value of derivative liability (119) (211)
Unrealized loss on marketable securities 30 29
Total Other (Income) Expense (373) 498
Net Loss $ (20,884) $ (58,013)
Net Loss Per Share - Basic and Diluted $ (0.66) $ (2.06)
Weighted average common shares outstanding - basic and diluted 31,868,024 28,155,624